Transcat, Inc. $TRNS Shares Sold by Sei Investments Co.

Sei Investments Co. cut its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 46.7% in the 1st quarter, Holdings Channel reports. The fund owned 18,397 shares of the scientific and technical instruments company’s stock after selling 16,136 shares during the quarter. Sei Investments Co.’s holdings in Transcat were worth $1,351,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Lazard Asset Management LLC purchased a new position in shares of Transcat in the 2nd quarter valued at approximately $54,000. Tower Research Capital LLC TRC increased its holdings in shares of Transcat by 245.5% in the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock valued at $97,000 after purchasing an additional 798 shares during the period. Marshall Wace LLP purchased a new stake in shares of Transcat during the fourth quarter worth approximately $236,000. Balyasny Asset Management L.P. acquired a new stake in shares of Transcat during the fourth quarter worth $247,000. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Transcat by 8.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company’s stock worth $299,000 after purchasing an additional 432 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Stock Performance

Shares of TRNS stock opened at $95.39 on Wednesday. The company has a market cap of $892.85 million, a price-to-earnings ratio of 257.81 and a beta of 0.68. The stock has a 50 day simple moving average of $89.75 and a 200-day simple moving average of $80.14. Transcat, Inc. has a 12-month low of $50.23 and a 12-month high of $98.36. The company has a current ratio of 2.49, a quick ratio of 2.11 and a debt-to-equity ratio of 0.36.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The business had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. On average, equities analysts forecast that Transcat, Inc. will post 1.74 EPS for the current year.

Insider Transactions at Transcat

In other Transcat news, Director Craig D. Cairns acquired 1,050 shares of the business’s stock in a transaction on Thursday, August 6th. The stock was purchased at an average price of $93.97 per share, for a total transaction of $98,668.50. Following the completion of the transaction, the director owned 1,480 shares of the company’s stock, valued at $139,075.60. The trade was a 244.19% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

TRNS has been the topic of several recent research reports. Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Northland Securities downgraded shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price objective for the company. in a research report on Wednesday, August 5th. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Finally, Weiss Ratings raised shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, May 28th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Transcat has an average rating of “Hold” and a consensus target price of $105.50.

Transcat Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.